An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016)

First Author: Wyszynski A
Attributed to:  King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddw223

PubMed Identifier: 27402876

Publication URI: http://europepmc.org/abstract/MED/27402876

Type: Journal Article/Review

Volume: 25

Parent Publication: Human molecular genetics

Issue: 17

ISSN: 0964-6906